Machiko Kurimoto

Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer.

T. Yoshimura, E. Usami, M. Kimura, 2017, Molecular and clinical oncology.

Efficacy of daiokanzoto in chronic constipation refractory to first-line laxatives.

T. Yoshimura, T. Sugiyama, Y. Shinoda, 2016, Biomedical Reports.

Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer.

T. Yoshimura, E. Usami, M. Kimura, 2017, Molecular and clinical oncology.